About Shanghai Kehua Bio-engineering Company

The company was founded in 1981 and listed on the small and medium board of the Shenzhen Stock Exchange in 2004 (stock code: 002022.SZ). It is an in vitro diagnostic company integrating R&D, production and sales, rich production experience and a complete medical diagnostic product line. It is headquartered in Shanghai, has R&D and production bases in Italy, Shenzhen, Xi'an, Suzhou and other countries and regions, and currently has nearly 2,000 employees. The company's main business is R&D, production and sales of in vitro diagnostic reagents and medical testing instruments. The company's independent products cover the three fields of molecular diagnosis, biochemical diagnosis, and immunological diagnosis. It has more than 100 reagents and instrument products, a rich product line, and a competitive advantage. The company's main products: liver function, kidney function, blood lipids, cardiomyocytes, electrolytes, specific proteins, immunological tests, thyroid, sex hormones, tumor markers, infectious diseases (hepatitis, AIDS, syphilis), cardiovascular and myocardial markers, glucose metabolism, enzyme markers, excellent C1800 fully automatic chemiluminescence measurement system, hepatitis B five-point test kit, hepatitis C virus antibody (anti-HCV) test kit, etc. Corporate honors: High-tech enterprises, 2022 Shanghai's top 100 manufacturing enterprises, China's top 100 innovative small and medium-sized enterprises, famous trademarks in Shanghai, etc.